Table 1.
Median fasting gastrin concentrations from each group included in this study.
| Normal Group | PPI groups | Active H. pylori with gastritis groups | Preneoplasia groups | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| All PPI | Standard Dose | High Dose | Low dose | All H. pylori | H. pylori without PPI | H. pylori with PPI | All preneoplasia patients | Antral preneoplasia with PPI | Antral preneoplasia without PPI | Corpus preneoplasia with PPI | Corpus preneoplasia without PPI | ||
| Number of Patients | 233 | 301 | 244 | 39 | 18 | 164 | 108 | 56 | 284 | 87 | 74 | 66 | 57 |
| Median age (IQR) | 52 (41-65) | 57 (47-67) | 58 (48-67) | 55 (44-65) | 62 (52-67) | 56 (46-66) | 56 (46-67) | 59 (45-64) | 65 (53-74) | 64 (53-72) | 65 (52-73) | 70 (61-77) | 64 (49-74) |
| Age range | 18-93 | 17-91 | 17-91 | 26-88 | 23-79 | 22-86 | 22-86 | 23-83 | 21-88 | 21-86 | 24-87 | 23-88 | 27-86 |
| Minimum value | 1 | 9 | 9 | 11 | 11 | 3 | 3 | 8 | 10 | 11 | 10 | 10 | 11 |
| Q1 | 15 | 29 | 30 | 30 | 25 | 22 | 20 | 33 | 24 | 32 | 19 | 38 | 26 |
| Median | 20 | 46 | 46 | 72 | 31 | 32 | 27 | 50 | 45 | 53 | 25 | 90 | 48 |
| Q3 | 26 | 84 | 80 | 131 | 52 | 62 | 48 | 109 | 116 | 100 | 42 | 186 | 260 |
| Maximum value | 720 | 650 | 440 | 650 | 128 | 295 | 295 | 295 | 1867 | 545 | 380 | 1290 | 1867 |
| Inter-quartile range (IQR) | 11 | 56 | 50 | 101 | 27 | 40 | 29 | 76 | 92 | 69 | 23 | 148 | 234 |
| Number >40pM | 21 (9%) | 168 (56%) | 138 (57%) | 25 (64%) | 5 (28%) | 64 (39%) | 32 (30%) | 32 (57%) | 152 (54%) | 51 (59%) | 22 (30%) | 48 (73%) | 31 (54%) |
| Number >100pM | 9 (4%) | 52 (17%) | 37 (15%) | 12 (31%) | 3 (17%) | 24 (15%) | 7 (6%) | 17 (30%) | 79 (28%) | 22 (25%) | 8 (11%) | 29 (44%) | 20 (35%) |